Star Imaging and Path Lab Starts CT Scan Operations at New Faridabad Facility

Key numbers

Market Cap	₹131.47 CrSmall Cap
PE Ratio (TTM)	6.82Sector PE 57.79
ROE Annual	16.6%Efficiency
Net Profit Growth	21.06%Annual YoY

Key highlights

• Commercial operations for the CT scan facility began on September 28, 2026
• Strategic partnership formed with R G Stone Urology & Laparoscopy Hospital in Faridabad
• Tie-up arrangement secured for a 5-year tenure with extension provisions
• Facility aims to expand diagnostic imaging availability in the Faridabad and NCR region
• The transaction is confirmed as a non-related party arrangement based on current data

Production Commenced — What It Means

Star Imaging has launched a specialized CT scan diagnostic unit within the premises of R G Stone Urology & Laparoscopy Hospital in Faridabad. This facility is part of a strategic partnership where Star Imaging provides advanced diagnostic imaging services at the hospital's AC Nagar location. The move positions the company to capture demand in a high-traffic medical hub, offering critical imaging support to the hospital's urology and laparoscopy patients.

This operational start is a key milestone in the company's regional growth strategy, focusing on high-end radiology services to complement its existing pathology network.

Path to This Milestone

• The facility is located at Plot No. A-6, Nehru Ground, Neelam Bata Road, AC Nagar, NIT, Faridabad
• Arrangement formalised via a tie-up with R G Stone Urology & Laparoscopy Hospital
• Operations commenced exactly on the scheduled date of September 28, 2026
• Agreement includes a 5-year initial term, extendable by mutual written consent
• Facility integration designed to strengthen the company's diagnostic service network in Haryana

Revenue Impact

While the immediate financial contribution remains unquantified at this early stage, the facility is expected to enhance the company's service operations and revenue streams. As a provider of CT scan services, which typically command higher price points than basic pathology tests, the unit will likely improve the overall service mix and average revenue per patient. The arrangement's commercial terms are based on a mutually agreed fee structure typical of hospital-diagnostic tie-ups.

This expansion aligns with the company's reported 6.85% annual revenue growth and 21.06% net profit growth recorded in the previous fiscal cycle.

Financial Context

Star Imaging and Path Lab maintains a disciplined financial profile with a TTM P/E of 6.82, which is significantly lower than the healthcare sector average of 57.79. The company has demonstrated efficient capital use with a Return on Equity of 16.6% and a Return on Assets of 12.55%. Its promoter holding remains stable at 71.92%, indicating strong internal confidence in the business model.

With a Piotroski Score of 5 and positive annual cash flow from operations at ₹23.34 crore, the company possesses the liquidity to fund its network expansions across the Delhi-NCR region.

Star Imaging And Path Lab · financial snapshot

Share price	₹75.47
Market capitalisation	₹131.47
Revenue (annual)	₹88.53
Net profit (annual)	₹19.28
P/E (TTM)	6.82×Sector 57.79×
Promoter holding	71.92%
FII holding	0.61%Current quarter

Reference market data from a third-party provider, as of the story. Not a valuation or a recommendation.